Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events

Company Overview - Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapies for advanced solid tumors and other serious diseases [3] - The company's lead product candidate, certepetide, is designed to enhance the effectiveness of anti-cancer drugs by activating a novel uptake pathway for better targeting of solid tumors [3] - Lisata has established significant commercial and R&D partnerships based on its CendR Platform® technology [3] - The company anticipates announcing multiple milestones over the next two years and believes its projected capital will support operations into early 2026, including data milestones from ongoing and planned clinical trials [3] Upcoming Events - Lisata management will participate in the BIO International Convention from June 3-6, 2024, in San Diego, California, with a presentation scheduled for June 3 at 2:15 p.m. Pacific Time [1] - The company will also present at the GCFF 2024 Bio Investing Conference on June 20, 2024, at 10:00 a.m. Pacific Time [2] - David J. Mazzo, PhD, President and CEO of Lisata, will be the presenter at both events [1][2]